Trial · NCT01290614
A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD)
NCT01290614, Phase 4, Completed, University of Minnesota; results first posted 2015-07-13
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD). Trials, record NCT01290614. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01290614
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD)
- NCT number
- NCT01290614
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 2,199 participants, actual
- Lead sponsor
- University of Minnesota
- Conditions
- Chronic Kidney Disease
- Interventions
- Pharmacist based QI program, Usual Care
- First posted
- 2011-02-07
- Last updated
- 2015-07-13
- Results first posted
- 2015-07-13
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Systolic Blood Pressure (SBP) | one year | Average SBP for those with a baseline BP \> 130/80 |
| Secondary | Number of Participants With PTH Measurement During the Study Period | one year | The primary process outcome was measurement of PTH during the study period. |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Systolic Blood Pressure (SBP) | one year | Baseline blood pressure \>130/80 mmHg | mmHg | MEAN |
| SECONDARY | Number of Participants With PTH Measurement During the Study Period | one year | participants | NUMBER |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Systolic Blood Pressure (SBP) | Pharmacist Intervention | 135.1 | Standard Deviation 17.4 | mmHg | |
| Systolic Blood Pressure (SBP) | Control - Usual Care | 134.4 | Standard Deviation 17.6 | mmHg | |
| Number of Participants With PTH Measurement During the Study Period | Pharmacist Intervention | 502 | participants | ||
| Number of Participants With PTH Measurement During the Study Period | Control - Usual Care | 182 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Pharmacist Intervention | 1,070 | |
| Overall Study | STARTED | Control - Usual Care | 1,129 | |
| Overall Study | COMPLETED | Pharmacist Intervention | 518 | |
| Overall Study | COMPLETED | Control - Usual Care | 1,129 | |
| Overall Study | NOT COMPLETED | Pharmacist Intervention | 552 | |
| Overall Study | NOT COMPLETED | Control - Usual Care | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Pharmacist Intervention | ||
| Total, all-cause mortality | Control - Usual Care | ||
| Total, other adverse events | Pharmacist Intervention | 0 | 1,070 |
| Total, other adverse events | Control - Usual Care | 0 | 1,129 |
| Total, serious adverse events | Pharmacist Intervention | 0 | 1,070 |
| Total, serious adverse events | Control - Usual Care | 0 | 1,129 |
Source ClinicalTrials.gov
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Pharmacist Intervention vs Control - Usual Care: Number of Participants With PTH Measurement During the Study Period | Trial comparisons |
| Pharmacist Intervention vs Control - Usual Care: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01290614
GET https://conductscience.org/api/trials/v1/NCT01290614/registered